Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stroke × Aspirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 8 Polycythemia Vera 5 Prostatic Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Colonic Neoplasms 4 Cardiovascular Diseases 4 Venous Thromboembolism 3 Precancerous Conditions 3 Ovarian Neoplasms 3 Neoplasms, Plasma Cell 3 Myeloproliferative Disorders 3 Melanoma 3 Esophageal Neoplasms 3 Barrett Esophagus 3 Thrombosis 2 Thromboembolism 2 Thrombocythemia, Essential 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Adenomatous Polyps 2 Vascular Diseases 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stroke 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1

Interventions

Nutrition Assessment 2 rimabotulinumtoxinB 1 Massage 1 Lysine Acetyltransferase 5 1 Hematologic Tests 1 Enoxaparin 1 Cholecalciferol 1 Botulinum Toxins, Type A 1 Aspirin 1 Animal Assisted Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01763606 2020-08-14

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Memorial Sloan Kettering Cancer Center

Phase NA Completed

20 enrolled 11 charts

Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡